Skip to content
TBC
lls
  • Home
  • All Episodes
    • CAR T-cell Therapy
    • Leukemia
    • Lymphoma
    • Myelodysplastic Syndromes
    • Myeloma & Amyloidosis
    • Pediatric and AYA
    • General Treatment & Support
  • Subscribe by Email
  • About
  • FAQs
  • Visit LLS.org

Author Archive: Nicole Gulinazzo

2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Understanding Waldenström Macroglobulinemia

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA

CAR T-cell Therapy in Review 2022: Updates in Treatment

Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX

Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II

Daphne Friedman, MD, Durham VA Health Care System, Durham, NC

AML: Insights, Updates, and Takeaways

Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting

Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY

Post navigation

« Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 17 Next »

Categories

  • All Episodes (102)
  • CAR T-cell Therapy (11)
  • Clinical Trials (4)
  • COVID-19 (7)
  • General Treatment & Support (34)
  • Genomics (3)
  • Health Equity (8)
  • Leukemia (23)
  • Lymphoma (15)
  • Minimal Residual Disease (MRD) (4)
  • Myelodysplastic Syndromes (6)
  • Myeloma & Amyloidosis (14)
  • Myeloproliferative Neoplasms (4)
  • Pediatric and AYA (13)
  • Rare Blood Cancers (4)
  • Transplantation (4)
  • Waldenström macroglobulinemia (2)

Find us on your favorite podcatchers

Apple PodcastsSpotifyAmazon MusicAndroidiHeartRadioJioSaavnPodchaserPodcast Indexby EmailRSSMore Subscribe Options
For a complete listing of continuing education programs, visit www.LLS.org/CE     |      Disclaimer
2024 Treating Blood Cancers Podcast Series – The Leukemia & Lymphoma Society